RESUMO
Neonatal exposure to a low dose of endosulfan may disrupt the expression of Wnt7a and ß-catenin during uterine development leading to the failure of uterine functional differentiation during implantation. New-born female Wistar rats were treated with vehicle, endosulfan (600 µg/kg/d, E600) or diethylstilbestrol (0.2 µg/kg/d, DES) on postnatal days (PNDs) 1, 3, 5 and 7. Subsequently, uterine histomorphology and the protein expression of Wnt7a and ß-catenin were evaluated on PND8, PND21 and gestational day (GD) 5 (pre-implantation period). In the E600 rats, Wnt7a and ß-catenin protein expression was increased in the epithelium on PND8, and Wnt7a expression was decreased in the endometrial glands on PND21. On GD5, the number of uterine glands was decreased in the E600-and DES-treated rats. In addition, Wnt7a expression was decreased in all uterine compartments, and ß-catenin expression was increased in the luminal and glandular epithelia of the E600-and DES-treated rats. Disruption of Wnt7a and ß-catenin uterine expression in the prepubertal and adult females altered the uterine preparation for embryo implantation, which could be associated with the subfertility triggered by endosulfan.
Assuntos
Endossulfano/efeitos adversos , Proteínas Proto-Oncogênicas/metabolismo , Útero/efeitos dos fármacos , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Animais , Animais Recém-Nascidos , Diferenciação Celular/efeitos dos fármacos , Dietilestilbestrol/toxicidade , Endossulfano/administração & dosagem , Feminino , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Ratos , Ratos Wistar , Útero/crescimento & desenvolvimento , Útero/metabolismoRESUMO
We investigated whether neonatal exposure to low doses of endosulfan affects fertility and uterine functional differentiation at pre-implantation in rats. Newborn female rats received the vehicle, 0.2 µg/kg/d of diethylstilbestrol (DES), 6 µg/kg/d of endosulfan (Endo6) or 600 µg/kg/d of endosulfan (Endo600) on postnatal days (PND) 1, 3, 5, and 7. On PND90, the rats were mated to evaluate their reproductive performance on gestational day (GD) 19 and their ovarian steroid serum levels, endometrial proliferation and implantation-associated proteins on GD5. DES and endosulfan decreased the pregnancy rate and the number of implantation sites. On GD5, DES and endosulfan did not change the serum levels of 17ß-estradiol (E2) and progesterone (P); the endometrial proliferation decreased, which was associated with silencing of Hoxa10 in the Endo600-treated rats. Both doses of endosulfan increased the progesterone receptor (PR) expression, whereas the higher dose led additionally to an increase in estrogen receptor alpha (ERα). In the Endo600-treated rats, the down-regulation of Hoxa10 was associated with a deregulation of the steroid receptor coregulators. Alterations in endometrial proliferation and the endocrine pathway of Hoxa10/steroid receptors/coregulators might be the mechanism of endosulfan-induced implantation failure.
Assuntos
Implantação do Embrião/efeitos dos fármacos , Endossulfano/administração & dosagem , Fertilidade/efeitos dos fármacos , Inseticidas/administração & dosagem , Útero/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Carcinógenos/administração & dosagem , Carcinógenos/toxicidade , Proliferação de Células/efeitos dos fármacos , Dietilestilbestrol/administração & dosagem , Dietilestilbestrol/toxicidade , Relação Dose-Resposta a Droga , Endossulfano/toxicidade , Feminino , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Inseticidas/toxicidade , Gravidez , Taxa de Gravidez , Ratos , Ratos Wistar , Esteroides/sangue , Útero/crescimento & desenvolvimentoRESUMO
Prolactinomas are the most prevalent type of secreting pituitary tumors in humans and generally respond well to a medical therapy with dopamine agonists. However, for patients exhibiting resistance to dopaminergic drugs, alternative treatments are desired. Antiangiogenic strategies might represent a potential therapy for these tumors. Thrombospondin 1 (TSP-1) is a large multifunctional glycoprotein involved in multiple biological processes including angiogenesis, apoptosis, and activation of TGF-ß1. Because tumors that overexpress TSP-1 grow more slowly, have fewer metastases, and have decreased angiogenesis, TSP-1 provides a novel target for cancer treatment. ABT-510 and ABT-898 are TSP-1 synthetic analogs that mimic its antiangiogenic action. In the present study, we explored the potential effect of ABT-510 and ABT-898 on experimental prolactinomas induced by chronic diethylstilbestrol (DES) treatment in female rats. We demonstrated that a 2-wk treatment with ABT-510 and ABT-898 counteracted the increase in pituitary size and serum prolactin levels as well as the pituitary proliferation rate induced by DES. These inhibitory effects on tumor growth could be mediated by the antiangiogenic properties of the drugs. We also demonstrated that ABT-510 and ABT-898, in addition to their described antiangiogenic effects, increased active TGF-ß1 level in the tumors. We postulate that the recovery of the local cytokine activation participates in the inhibition of lactotrope function. These results place these synthetic TSP-1 analogs as potential alternative or complementary treatments in dopamine agonist-resistant prolactinomas.
Assuntos
Oligopeptídeos/uso terapêutico , Prolactinoma/tratamento farmacológico , Trombospondina 1/química , Fator de Crescimento Transformador beta1/metabolismo , Animais , Dietilestilbestrol/toxicidade , Feminino , Oligopeptídeos/química , Prolactinoma/induzido quimicamente , Prolactinoma/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
The current study examined the consequences of perinatal (gestation+lactation) exposure to Bisphenol A (BPA) or diethylstilbestrol (DES) on F1 mammary gland (MG) differentiation. BPA (0, 0.7 or 64 µg/kg bw/day) or DES (6 µg/kg bw/day) was administered in the drinking water of F0 rats from gestational day 9 (GD9) until weaning. F1 females were bred, MG samples obtained on GD18 and GD21, and, during lactation, milk yield and milk protein composition were assessed. On GD18, there was a decrease in α-lactalbumin and ß-casein levels that was accompanied by reduced prolactin receptor and Stat5a/b expression. On GD21, delayed histological MG differentiation was observed. ß-Casein levels remained decreased on GD21 and in milk samples. Moreover, the BPA- and DES-exposed groups had an altered milk yield pattern during lactation. The long-lasting effects of perinatal exposure to low doses of xenoestrogens included delayed MG differentiation, altered milk yield and modified milk composition.
Assuntos
Dietilestilbestrol/toxicidade , Estrogênios/toxicidade , Lactação/efeitos dos fármacos , Glândulas Mamárias Animais/efeitos dos fármacos , Fenóis/toxicidade , Animais , Compostos Benzidrílicos , Caseínas/metabolismo , Feminino , Lactação/fisiologia , Glândulas Mamárias Animais/crescimento & desenvolvimento , Troca Materno-Fetal , Leite/química , Leite/efeitos dos fármacos , Gravidez , Ratos , Ratos WistarRESUMO
This study investigates the effects of neonatal exposure to low doses of endosulfan on the expression of proteins regulating uterine development and differentiation. Female pups received vehicle, endosulfan (Endo6: 6 µg/kg, Endo600: 600 µg/kg) or diethylstilbestrol (DES: 0.2 µg/kg) from postnatal day 1 (PND1) to PND7. The uterine expression of estrogen receptor alpha (ERα), progesterone receptor (PR), Hoxa10 and alpha smooth muscle actin (α-SMA) was detected by immunohistochemistry on PND8 (neonatal period) and PND21 (prepubertal period), to evaluate acute and short-term responses. ERα, Hoxa10 and α-SMA were induced in the Endo600 group in both ages, while a striking decrease in PR expression was detected in the prepubertal rats following each dose of endosulfan. DES treatment deregulated ERα and Hoxa10 uterine expression at each age. Studies are currently underway to investigate whether the dysregulation of steroid receptors, Hoxa10 and α-SMA observed following neonatal exposure to endosulfan affect uterine functions in adulthood.
Assuntos
Diferenciação Celular/efeitos dos fármacos , Disruptores Endócrinos/toxicidade , Endossulfano/toxicidade , Inseticidas/toxicidade , Útero/efeitos dos fármacos , Actinas/metabolismo , Animais , Animais Recém-Nascidos , Dietilestilbestrol/toxicidade , Relação Dose-Resposta a Droga , Disruptores Endócrinos/administração & dosagem , Endossulfano/administração & dosagem , Receptor alfa de Estrogênio/efeitos dos fármacos , Receptor alfa de Estrogênio/metabolismo , Feminino , Proteínas Homeobox A10 , Proteínas de Homeodomínio/metabolismo , Imuno-Histoquímica , Inseticidas/administração & dosagem , Gravidez , Ratos , Ratos Wistar , Receptores de Progesterona/efeitos dos fármacos , Receptores de Progesterona/metabolismo , Fatores de Tempo , Útero/crescimento & desenvolvimento , Útero/metabolismoRESUMO
We hypothesized that neonatal xenoestrogen exposure affects the ovarian follicular dynamics in lambs. Female lambs were exposed from postnatal day (PND) 1-14 to low doses of diethylstilbestrol (DES) or bisphenol A (BPA). At PND 30, the follicular dynamics and ovarian biomarkers (ERα, ERß, AR, Ki67, p27) were evaluated. Lambs exposed to DES or BPA showed a decline in the stock of primordial follicles with stimulation of follicular development. BPA reduced ovarian weight and increased the number of multioocyte follicles. BPA promoted proliferation of granulosa/theca cells in antral follicles, and increased both the number of antral atretic follicles and p27 expression. Neonatal exposure to BPA or DES reduced the primordial follicle pool by stimulating their initial recruitment and subsequent follicle development until antral stage. In prepubertal lambs, the accelerated folliculogenesis resulted in increased incidence of atretic follicles. These alterations may affect the ovarian function in the adult.
Assuntos
Dietilestilbestrol/toxicidade , Estrogênios não Esteroides/toxicidade , Folículo Ovariano/efeitos dos fármacos , Fenóis/toxicidade , Animais , Animais Recém-Nascidos , Compostos Benzidrílicos , Inibidor de Quinase Dependente de Ciclina p27/metabolismo , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/metabolismo , Feminino , Antígeno Ki-67/metabolismo , Tamanho do Órgão/efeitos dos fármacos , Folículo Ovariano/metabolismo , Folículo Ovariano/patologia , Ovário/efeitos dos fármacos , Ovário/crescimento & desenvolvimento , Receptores Androgênicos/metabolismo , Carneiro DomésticoRESUMO
BACKGROUND: Early-life exposures to hormonally active compounds and other factors may affect later response to estrogen or progesterone and hence may influence development of uterine leiomyomata (fibroids). OBJECTIVES: We evaluated associations of in utero and early-life exposures, including soy formula, with self-report of physician-diagnosed fibroids by 35 years of age. METHODS: Our study included 19,972 non-Hispanic white women who were 35-59 years of age when they enrolled in the Sister Study in 20032007. We estimated risk ratios (RRs) and 95% confidence intervals (CIs) using log-binomial regression models for fibroid associations with adjustment for participant's age and education, maternal age at participant's birth, birth order, and childhood family income. RESULTS: Greater risk of early fibroid diagnosis was associated with soy formula during infancy (RR = 1.25; 95% CI, 0.971.61), maternal prepregnancy diabetes (RR = 2.05; 95% CI, 1.163.63), low childhood socioeconomic status (RR = 1.28; 95% CI, 1.011.63), and gestational age at birth (RR = 1.64; 95% CI, 1.272.13, for being born at least 1 month early). In utero diethylstilbestrol (DES) exposure was also associated with early fibroid diagnosis (RR = 1.42; 95% CI, 1.131.80), but this association was driven by women reporting probable rather than definite exposure. CONCLUSIONS: There are plausible biological pathways by which these early-life factors could promote fibroid pathogenesis. This is the first epidemiologic study to evaluate such exposures, with the exception of in utero DES, in relation to fibroid risk, and replication of findings in other populations is needed.
Assuntos
Dietilestilbestrol/toxicidade , Estrogênios não Esteroides/toxicidade , Leiomioma/diagnóstico , Leiomioma/etiologia , Exposição Materna/efeitos adversos , Efeitos Tardios da Exposição Pré-Natal/etiologia , Irmãos , Adulto , Idade de Início , Diabetes Gestacional , Feminino , Humanos , Fórmulas Infantis , Recém-Nascido , Recém-Nascido Prematuro , Leiomioma/induzido quimicamente , Leiomioma/epidemiologia , Exposição Materna/estatística & dados numéricos , Pessoa de Meia-Idade , Gravidez , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Porto Rico/epidemiologia , Fatores Socioeconômicos , Glycine max , Fatores de Tempo , Estados Unidos/epidemiologiaRESUMO
Environmental xenoestrogens pose a significant health risk for all living organisms. There is growing evidence concerning the different susceptibility to xenoestrogens of developing and adult organisms, but little is known about their genotoxicity in pre-pubertal mammals. In the present study, we developed an animal model to test the sex- and age-specific genotoxicity of the synthetic estrogen diethylstilbestrol (DES) on the reticulocytes of 3-week-old pre-pubertal and 12-week-old adult BALB/CJ mice using the in vivo micronucleus (MN) assay. DES was administered intraperitoneally at doses of 0.05, 0.5, and 5 µg/kg for 3 days and animals were sampled 48, 72 and 96 h, and 2 weeks after exposure. Five animals were analyzed for each dose, sex, and age group. After the DES dose of 0.05 µg/kg, pre-pubertal mice showed a significant increase in MN frequency (P < 0.001), while adults continued to show reference values (5.3 vs 1.0 MN/1000 reticulocytes). At doses of 0.5 and 5 µg/kg, MN frequency significantly increased in both age groups. In pre-pubertal male animals, MN frequency remained above reference values for 2 weeks after exposure. Our animal model for pre-pubertal genotoxicity assessment using the in vivo MN assay proved to be sensitive enough to distinguish age and sex differences in genome damage caused by DES. This synthetic estrogen was found to be more genotoxic in pre-pubertal mice, males in particular. Our results are relevant for future investigations and the preparation of legislation for drugs and environmentally emitted agents, which should incorporate specific age and gender susceptibility.
Assuntos
Animais , Feminino , Masculino , Camundongos , Carcinógenos/toxicidade , Dietilestilbestrol/toxicidade , Modelos Animais , Reticulócitos/efeitos dos fármacos , Fatores Etários , Camundongos Endogâmicos BALB C , Testes para Micronúcleos , Fatores SexuaisRESUMO
Environmental xenoestrogens pose a significant health risk for all living organisms. There is growing evidence concerning the different susceptibility to xenoestrogens of developing and adult organisms, but little is known about their genotoxicity in pre-pubertal mammals. In the present study, we developed an animal model to test the sex- and age-specific genotoxicity of the synthetic estrogen diethylstilbestrol (DES) on the reticulocytes of 3-week-old pre-pubertal and 12-week-old adult BALB/CJ mice using the in vivo micronucleus (MN) assay. DES was administered intraperitoneally at doses of 0.05, 0.5, and 5 microg/kg for 3 days and animals were sampled 48, 72 and 96 h, and 2 weeks after exposure. Five animals were analyzed for each dose, sex, and age group. After the DES dose of 0.05 microg/kg, pre-pubertal mice showed a significant increase in MN frequency (P < 0.001), while adults continued to show reference values (5.3 vs 1.0 MN/1000 reticulocytes). At doses of 0.5 and 5 microg/kg, MN frequency significantly increased in both age groups. In pre-pubertal male animals, MN frequency remained above reference values for 2 weeks after exposure. Our animal model for pre-pubertal genotoxicity assessment using the in vivo MN assay proved to be sensitive enough to distinguish age and sex differences in genome damage caused by DES. This synthetic estrogen was found to be more genotoxic in pre-pubertal mice, males in particular. Our results are relevant for future investigations and the preparation of legislation for drugs and environmentally emitted agents, which should incorporate specific age and gender susceptibility.
Assuntos
Carcinógenos/toxicidade , Dietilestilbestrol/toxicidade , Modelos Animais , Reticulócitos/efeitos dos fármacos , Fatores Etários , Animais , Feminino , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Testes para Micronúcleos , Fatores SexuaisRESUMO
Morphoregulator genes like members of the Hox gene family regulate uterine development and are associated with endocrine-related processes such as endometrial proliferation and differentiation in the adult uterus. Exposure to neonatal endocrine disruptors could affect signaling events governed by Hox genes, altering the developmental trajectory of the uterus with lasting consequences. We investigated whether neonatal exposure to bisphenol A (BPA) alters Hoxa10 and Hoxa11 mRNA uterine expression shortly after treatment as well as in the adult. Moreover, we studied whether xenoestrogen exposure may affect the adult uterine response to hormonal stimuli. Newborn females received vehicle, 0.05 mg/kg.d BPA, 20 mg/kg*d BPA, or diethylstilbestrol (0.2 microg/kg*d) on postnatal d 1, 3, 5, and 7). At postnatal d 8, real time RT-PCR assays showed a decrease in Hoxa10 and Hoxa11 expression in all xenoestrogen-treated groups. To evaluate the long-term effects, we used adult ovariectomized rats with hormonal replacement. The subepithelial stroma in BPA- and diethylstilbestrol-treated animals showed an impaired proliferative response to steroid treatment associated with a silencing of Hoxa10 but not associated with changes in the methylation pattern of the Hoxa10 promoter. BPA animals showed that the Hoxa10 reduction was accompanied by an increased stromal expression of the silencing mediator for retinoic acid and thyroid hormone receptor. The spatial coexpression of steroid receptors Hoxa10 and silencing mediator for retinoic acid and thyroid hormone receptor was established using immunofluorescence. Our data indicate that postnatal BPA exposure affects the steroid hormone-responsiveness of uterine stroma in adulthood. Whether this impaired hormonal response is associated with effects on uterine receptivity and decidualization is currently under investigation.
Assuntos
Hormônios Esteroides Gonadais/farmacologia , Fenóis/toxicidade , Útero/efeitos dos fármacos , Útero/crescimento & desenvolvimento , Algoritmos , Animais , Animais Recém-Nascidos , Compostos Benzidrílicos , Proliferação de Células/efeitos dos fármacos , Dietilestilbestrol/farmacologia , Dietilestilbestrol/toxicidade , Estrogênios não Esteroides/farmacologia , Estrogênios não Esteroides/toxicidade , Feminino , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Hormônios Esteroides Gonadais/metabolismo , Proteínas Homeobox A10 , Proteínas de Homeodomínio/genética , Proteínas de Homeodomínio/metabolismo , Modelos Biológicos , Ovário/efeitos dos fármacos , Ovário/crescimento & desenvolvimento , Ovário/metabolismo , Fenóis/farmacologia , Ratos , Ratos Wistar , Células Estromais/efeitos dos fármacos , Células Estromais/fisiologia , Útero/metabolismo , Útero/fisiopatologiaRESUMO
Female F344 rats treated chronically with diethylstilbestrol (DES) develop prolactin (PRL)-producing pituitary tumors. These tumors are larger in female than in male rats. To investigate gender differences in DES-induced pituitary tumor formation, we employed female and male rats and neonatally androgenized females, which received 100 microg of testosterone propionate (TP) after birth. At 3 months of age, all rats were deprived of their gonads and divided into control and DES-treated groups. Forty days after beginning treatment, control pituitary weight and serum PRL were similar in gonadectomized males (GDX), ovariectomized females (OVX) and androgenized-ovariectomized females (OVX + TP), but weight of DES-induced tumors was 2.5-fold higher and serum PRL 5.6-fold higher in OVX + DES than in GDX + DES or OXV + TP + DES (p<0.001). At the pituitary level, nuclear estrogen receptors (NE(2)R) amounted to >100 fmol/mg DNA in all rats receiving DES. However, NE(2)R were lower in OVX + DES (101.3+/-9.0 fmol/mg DNA) than in GDX + DES (174.6 +/-16.8; p<0.05) and in OXV + DES + TP (150.3+/-27.7; p<0.05). A similar profile was found for cytosolic progestin receptors. Using electron microscopy (EM), hyperplasia/hypertrophy of lactotropes was found in all DES-stimulated pituitaries. However, tumors of OVX + DES rats were enriched in hyperstimulated typical lactotropes, i.e., cells with high rate of hormonal synthesis, processing and secretion. Instead, tumors from GDX + DES and OVX + TP + DES rats were a mixture of typical and atypical lactotropes, i.e. a cell subpopulation with refractory secretory response and a few gonadotropes. In agreement with these data, immunoreactive pituitary PRL was lower in OVX + DES than in OVX + TP + DES and GDX + DES groups. Thus, differences in the sensitivity to DES, serum and tumor PRL, NE(2)R and progestin receptors between estrogenized female rats on one side and male and TP-androgenized females on the other, may by due in part to heterogeneity of cell populations. Our data further suggest that neonatal hypothalamic exposure to androgens, as in normal males or androgenized females with masculinization of hypothalamic centers, may condition the response to DES stimulation later in life.
Assuntos
Carcinógenos/toxicidade , Dietilestilbestrol/toxicidade , Neoplasias Hipofisárias/induzido quimicamente , Neoplasias Hipofisárias/patologia , Prolactina/metabolismo , Prolactinoma/induzido quimicamente , Prolactinoma/patologia , Animais , Citosol/metabolismo , Dietilestilbestrol/sangue , Feminino , Masculino , Microscopia Eletrônica , Orquiectomia , Tamanho do Órgão/fisiologia , Ovariectomia , Neoplasias Hipofisárias/metabolismo , Prolactina/sangue , Prolactinoma/metabolismo , Ratos , Ratos Endogâmicos F344 , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Receptores de Esteroides/metabolismo , Caracteres SexuaisRESUMO
In estrogen-induced pituitary hyperplasia AII-evoked prolactin release is decreased and the octapeptide does not generate a spike elevation in [Ca(2+)](i) in vitro. We studied whether or not bromocriptine could restore AII response in diethylstilbestrol treated rats. Co-administration of bromocriptine resulted in involution of pituitary size and lowering of serum prolactin. In vitro, prolactin release per cell was reduced in the hyperplastic group, and levels were not significantly increased by in vivo bromocriptine treatment. Immunocytochemical analysis revealed that hyperplastic pituitaries contained fewer prolactin granules than control pituitaries, and that bromocriptine, did not increase prolactin storage. Nevertheless, in this group, prolactin response to AII increased, and AII evoked a consistent spike in [Ca(2+)](i), albeit lower than in the control group. Such spike was abolished by thapsigargin, and not by removal of extracellular calcium or by K(+), indicating that it was mainly dependent on intracellular calcium stores, as in normal cells. We conclude that bromocriptine treatment partially restores AII response in the hyperplastic pituitary.
Assuntos
Angiotensina II/farmacologia , Bromocriptina/farmacologia , Hipófise/efeitos dos fármacos , Hipófise/metabolismo , Prolactina/metabolismo , Animais , Cálcio/metabolismo , Canais de Cálcio/metabolismo , Dietilestilbestrol/toxicidade , Feminino , Hiperplasia/induzido quimicamente , Hiperplasia/fisiopatologia , Imuno-Histoquímica , Técnicas In Vitro , Hipófise/patologia , Potássio/metabolismo , Prolactina/sangue , Ratos , Ratos Sprague-Dawley , Tapsigargina/farmacologiaRESUMO
Chronic exposure of F344 rats to diethylstilbestrol (DES) induces pituitary tumors (DES-T) composed of proliferating lactotrophs. Presently, we studied the effect of progestins on parameters related to tumor growth and function, due to previous evidences of progesterone antagonism of pituitary tumorigenesis acting at pituitary and hypothalamic levels [Piroli, G., Grillo, C., Ferrini, M., Lux-Lantos, V. and De Nicola, A. F., Antagonism by progesterone of diethylstilbestrol-induced pituitary tumorigenesis in Fischer 344 rats: Effects on sex steroid receptors and tyrosine hydroxylase mRNA, Neuroendocrinology, 1996, 63, 530-539]. In search of a quantitatively more important effect, animals bearing DES-T were treated with synthetic progestins. Competition assays using DES-T as source of progestin receptors indicated that levonorgestrel (LNG), gestodene and R5020 showed higher affinities (IC50 1-2 nM) than progesterone, norethisterone and medroxyprogesterone (IC50 10-25 nM). Treatment with LNG reduced DES-T weight by 45%, and serum PRL by one half. Small (monomeric) and big (polymeric) PRL increased 5- and 2.5-fold, respectively, in DES-T in comparison with pituitaries of ovariectomized (OVX) rats. However, LNG produced no changes indicating that synthesis and storage of PRL was conserved in rats receiving both hormonal treatments. DES induced a 15-fold increase in cell proliferation, measured as bromodeoxyuridine incorporation into cell nuclei, in comparison to OVX rats, while LNG treatment of DES-T bearing rats reduced this index by 72%. Electron microscopic images showed that LNG markedly reduced hypertrophy and hyperplasia of lactotropes, increasing the proportions of degenerating cells and cells of high electronic density with alterations of cytoplasmic organelles. However, histopathological signs of apoptosis were absent. Therefore, reduced cell proliferation and non-apoptotic cell death are part of the mechanisms employed by progestins to antagonize tumorigenesis at the pituitary level. The results may open a new therapeutic strategy for treatment of PRL secreting adenoma in humans.
Assuntos
Neoplasias Hormônio-Dependentes/prevenção & controle , Neoplasias Hipofisárias/prevenção & controle , Congêneres da Progesterona/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Dietilestilbestrol/toxicidade , Feminino , Levanogestrel/metabolismo , Levanogestrel/farmacologia , Microscopia Eletrônica , Neoplasias Hormônio-Dependentes/induzido quimicamente , Neoplasias Hormônio-Dependentes/metabolismo , Ovariectomia , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo , Adeno-Hipófise/ultraestrutura , Neoplasias Hipofisárias/induzido quimicamente , Neoplasias Hipofisárias/metabolismo , Congêneres da Progesterona/metabolismo , Prolactina/sangue , Prolactina/metabolismo , Ratos , Ratos Endogâmicos F344RESUMO
Treatment of F344 rats with diethylstilbestrol (DES) for 1-2 months induces a prolactin (PRL)-secreting pituitary adenoma. After 8 weeks of DES treatment, we have shown that the ratio of regulatory subunits of the cAMP-dependent protein kinase (RI/RII) increased in the tumors. Presently we report the variations in RI/RII ratio, pituitary weight, DNA content, serum PRL, nuclear estrogen receptor (E2R) and of ornithine decarboxylase (ODC) activity from the time of DES pellet implantation until 8 weeks. Pituitary weight, DNA content and serum PRL rose significantly at 4 weeks with a maximum at 6-8 weeks, and significantly correlated with each other. E2R and ODC activity increased from week 1 onwards, with a maximum at 2 weeks and decreased at 8 weeks. Both variables showed a positive correlation but neither E2R nor ODC activity correlated with pituitary weight, DNA or serum PRL. Values for RI remained stable with time, but RII decreased progressively. The RI/RII ratio was maintained around unity between 1-4 weeks, increasing to 1.6-2 thereafter. This ratio positively correlated with pituitary weight and DNA. It is suggested that during tumor induction by estrogen in a sensitive strain of rats, growth signals with different time-courses become activated. Increases in pituitary weight and DNA content, indicators of mammotroph hypertrophy and hyperplasia, were preceded by early rises in E2R and ODC activity. Increases in the RI/RII ratio accompanied the adenomatous change, suggesting their role in cell transformation after 6 weeks of estrogen exposure.
Assuntos
Adenoma/induzido quimicamente , Adenoma/metabolismo , Dietilestilbestrol/toxicidade , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo , Neoplasias Hipofisárias/induzido quimicamente , Neoplasias Hipofisárias/metabolismo , Animais , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , DNA/metabolismo , DNA de Neoplasias/metabolismo , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ornitina Descarboxilase/metabolismo , Adeno-Hipófise/patologia , Prolactina/sangue , Prolactina/metabolismo , Ratos , Ratos Endogâmicos F344 , Receptores de Estradiol/metabolismo , Fatores de TempoRESUMO
In this paper we report the cytogenetic activity of ethanol (EA) and its main metabolic derivative, acetaldehyde (AA) in cultured Chinese hamster cells. AA induced an increase of aneuploidy and chromosome breaks and exchanges. EA only induced an increase of achromatic lesions (gaps). However, following treatment with AA, the most notable effect was an increase of hypodiploid cells and a parallel increase of multinucleated interphase cells, the frequency of hyperdiploid cells being considerably lower. A strong correlation (r = 0.93, P less than 0.01) has been found on comparing the frequency of hypodiploid cells to the frequency of hyperdiploid plus multinucleated interphase cells. We conclude that there exists a higher chance of hypodiploid cells reaching the second mitosis after treatment and that the main effect of AA is the induction of hypodiploidy rather than hyperdiploidy and chromosome aberrations.